Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This publication and the expert advisory group meeting (2 September 2016, London, UK), on which the supplement is based, were sponsored by Bayer to explore and discuss multidisciplinary practice initiatives and developments in the management of diabetic eye disease. Development of this publication was sponsored by Bayer UK plc. All authors contributed to the development and finalisation of the manuscript and retained full control of the editorial content. Medical writing and research assistance was provided independently to the Action on DMO group, a service funded by Bayer and provided by Rod McNeil Associates.
